Table 1.
Clinical characteristics of overall sample
| Women | Men | |
|---|---|---|
| n | 1,611 | 1,737 |
| Age (years) | 52.2 ± 9.9 | 49.8 ± 10.7 |
| BMI (kg/m2) | 27.1 ± 5.8 | 28.4 ± 4.5 |
| Waist circumference (cm) | 93 ± 15 | 101 ± 12 |
| Low HDL cholesterol (%)* | 26 | 33 |
| Elevated triglycerides (%)† | 27 | 44 |
| Hypertension (%) | 26.8 | 32.0 |
| Impaired fasting glucose (%)‡ | 19 | 40 |
| Diabetes (%) | 5.6 | 7.4 |
| Metabolic syndrome (%) | 28 | 38 |
| CVD (%) | 4.3 | 7.8 |
| Hypertension treatment (%) | 18.7 | 19.8 |
| Lipid treatment (%) | 10.7 | 17.7 |
| Diabetes treatment (%) | 3.3 | 3.9 |
| SAT (cm3) | 3,148 ± 1,519 | 2,640 ± 1,206 |
| VAT (cm3) | 1,365 ± 832 | 2,243 ± 1,023 |
Data are means ± SD or %.
*
Low HDL defined as <40 mg/dl (men) and <50 (women).
†
Elevated triglycerides defined as ≥150 mg/dl or lipid treatment.
‡
Defined as fasting plasma glucose 100–125 mg/dl in the absence of diabetes treatment.